By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. 

135 Clarendon Street #14R

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


Company News
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014 3:27:58 PM
Boston CEO Conference To Feature Ceos Of Aegerion Pharmaceuticals, Inc. (AEGR), Alkermes plc (ALKS), Alnylam Pharmaceuticals (ALNY), Flex Pharma, Genzyme Corporation (GENZ), Infinity Pharmaceuticals Inc. (INFI), OvaScience (OVAS), Sarepta Therapeutics (SRPT), Tesaro, Inc. (TSRO), Verastem, Inc. (VSTM) And Others June 4th And 5th 5/20/2014 7:03:42 AM
Tesaro, Inc. (TSRO) Announces Election Of Earl M. (Duke) Collier, Jr. To Board Of Directors And Results Of Annual Stockholder Meeting 5/16/2014 9:26:32 AM
Tesaro, Inc. (TSRO) To Present At The UBS 2014 Global Healthcare Conference 5/14/2014 11:48:56 AM
Weak Phase 3 Nausea Drug Data Knocks Back Tesaro, Inc.'s Shares; Stock Down -24.75% At Market Close (Dec. 23, 2013) 12/23/2013 6:52:31 AM
Tesaro, Inc. Announces Presentation of Rolapitant Pharmacokinetic (PK) Data at the MASCC/ISOO International Symposium 6/28/2013 9:00:12 AM
Tesaro, Inc. and the European Network of Gynecological Oncological Trial Groups (ENGOT) Forge Partnership to Develop Niraparib for Ovarian Cancer 6/3/2013 9:41:24 AM
Tesaro, Inc., Breast International Group (BIG), and the European Organization for Research and Treatment of Cancer Announce Collaboration for Niraparib Clinical Development in Breast Cancer 6/3/2013 9:38:38 AM
Tesaro, Inc. Nets $91 Million 3/7/2013 8:46:30 AM
Tesaro, Inc. Announces Third Quarter 2012 Operating Results 10/26/2012 6:42:21 AM